Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.25 trillion and total revenue of $117.12 billion.
Market Cap
1.25T
Revenue
117.12B
Profits
-35.33B
PE Ratio
n/a
Profit Margin
-30.17%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.80B | -2.10% | 832,628 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.39B | -1.72% | 527,740 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 79.89B | -1.25% | 21,566,922 | 2.23B |
| 4 | ARGX | argenx SE | 54.78B | -0.23% | 298,966 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 42.94B | -1.21% | 315,805 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.08B | -0.37% | 1,721,966 | - |
| 7 | RPRX | Royalty Pharma plc | 36.72B | 0.17% | 4,015,552 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.98B | -1.43% | 1,055,960 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.36B | -2.56% | 8,225,577 | 7.53M |
| 10 | GMAB | Genmab A/S | 23.67B | 9.47% | 13,000,825 | 4.13B |
| 11 | INCY | Incyte Corporation | 23.45B | -1.04% | 1,476,823 | 5.82B |
| 12 | BNTX | BioNTech SE | 22.13B | -1.73% | 838,703 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.39B | -1.76% | 3,414,135 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 15.99B | -1.19% | 2,066,169 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 15.98B | 0.16% | 575,676 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.26B | 0.88% | 1,530,354 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.89B | -0.30% | 560,601 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.40B | 0.65% | 2,403,444 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.37B | -0.51% | 3,210,684 | - |
| 20 | TECH | Bio-Techne Corporation | 11.38B | -0.10% | 1,898,445 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.83B | -1.20% | 1,682,822 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.03B | -4.21% | 234,853 | 1.28B |
| 23 | PCVX | Vaxcyte, Inc. | 9.51B | -3.85% | 2,062,419 | - |
| 24 | CORT | Corcept Therapeutics Incorporated | 9.28B | -20.13% | 3,098,611 | 830.81M |
| 25 | KRYS | Krystal Biotech, Inc. | 9.22B | -2.70% | 270,066 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 9.21B | -0.08% | 517,065 | 105.00M |
| 27 | CAI | Caris Life Sciences, Inc. | 9.04B | 0.91% | 2,321,776 | 989.61M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 8.96B | -0.79% | 409,357 | 281.99M |
| 29 | TWST | Twist Bioscience Corporation | 8.77B | 3.28% | 1,857,986 | 431.80M |
| 30 | IBRX | ImmunityBio, Inc. | 8.71B | -1.08% | 5,943,796 | 165.79M |
| 31 | CYTK | Cytokinetics, Incorporated | 8.51B | -1.76% | 985,633 | 67.67M |
| 32 | SYRE | Spyre Therapeutics, Inc. | 8.44B | -2.17% | 503,013 | - |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.20B | -0.58% | 871,821 | 669.50M |
| 34 | TGTX | TG Therapeutics, Inc. | 7.68B | 1.90% | 1,978,091 | 799.54M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.68B | -2.46% | 432,466 | 5.33M |
| 36 | AXSM | Axsome Therapeutics, Inc. | 7.60B | -7.07% | 1,593,569 | 776.57M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.13B | -2.23% | 3,015,008 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.06B | -2.30% | 371,623 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.38B | -0.35% | 7,760,273 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | -1.79% | 536,876 | 239.92M |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 6.05B | -1.39% | 366,546 | 290.54M |
| 42 | BLTE | Belite Bio, Inc | 5.93B | -1.96% | 49,854 | - |
| 43 | IMVT | Immunovant, Inc. | 5.87B | -2.37% | 641,437 | - |
| 44 | MANE | Veradermics, Incorporated | 5.80B | 0.21% | 426,424 | - |
| 45 | KOD | Kodiak Sciences Inc. | 5.50B | 2.16% | 526,946 | - |
| 46 | CGON | CG Oncology, Inc. | 5.47B | -1.33% | 1,064,999 | 6.23M |
| 47 | COGT | Cogent Biosciences, Inc. | 5.42B | -0.32% | 1,774,741 | - |
| 48 | ORKA | Oruka Therapeutics, Inc. | 5.31B | -1.23% | 513,996 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.22B | -3.26% | 788,216 | 618.07M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.06B | -3.89% | 674,207 | 1.01B |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.05B | -1.12% | 1,207,039 | - |
| 52 | ERAS | Erasca, Inc. | 5.03B | 2.49% | 3,499,957 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 4.79B | -0.92% | 1,754,535 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 4.78B | -1.20% | 1,925,646 | 13.39M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.72B | -4.48% | 2,314,484 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.29B | -2.23% | 379,235 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -1.70% | 911,110 | - |
| 58 | RLAY | Relay Therapeutics, Inc. | 3.98B | -0.87% | 1,898,941 | 10.35M |
| 59 | TNGX | Tango Therapeutics, Inc. | 3.94B | -16.43% | 15,853,112 | 53.81M |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.92B | -3.11% | 1,894,086 | 463.98M |
| 61 | ABCL | AbCellera Biologics Inc. | 3.83B | 3.96% | 3,032,550 | 66.17M |
| 62 | LEGN | Legend Biotech Corporation | 3.73B | 1.96% | 979,577 | 1.27B |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.42B | -3.18% | 636,596 | 7.50M |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | -2.86% | 1,066,084 | 1.14B |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.35B | -3.90% | 1,128,970 | 234.13M |
| 66 | IRON | Disc Medicine, Inc. | 3.31B | -0.69% | 1,963,100 | - |
| 67 | CELC | Celcuity Inc. | 3.19B | -0.49% | 1,316,079 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.07B | -4.09% | 413,442 | 890.79M |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.04B | -0.98% | 2,298,505 | - |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.02B | -9.21% | 1,820,958 | 148.00K |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | -5.38% | 556,620 | 606.33M |
| 72 | DNLI | Denali Therapeutics Inc. | 2.94B | -1.34% | 1,005,558 | 3.60M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.92B | -0.95% | 2,134,279 | - |
| 74 | VKTX | Viking Therapeutics, Inc. | 2.85B | -5.54% | 4,675,336 | - |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -0.67% | 1,910,422 | 701.94M |
| 76 | ZLAB | Zai Lab Limited | 2.70B | 9.03% | 3,691,476 | 449.61M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.63B | -4.24% | 5,925,217 | 117.00M |
| 78 | VRDN | Viridian Therapeutics, Inc. | 2.53B | -1.97% | 1,179,023 | 71.13M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.40B | -2.08% | 1,596,244 | 156.04M |
| 80 | ADMA | ADMA Biologics, Inc. | 2.39B | -2.47% | 1,740,919 | 512.28M |
| 81 | NAMS | NewAmsterdam Pharma Company N.V. | 2.36B | -8.67% | 2,311,263 | 7.12M |
| 82 | MBX | MBX Biosciences, Inc. | 2.34B | -3.88% | 581,557 | - |
| 83 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | 1.67% | 3,279,156 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.30B | 0.97% | 879,734 | 158.00K |
| 85 | FTRE | Fortrea Holdings Inc. | 2.25B | -1.21% | 1,000,270 | 2.68B |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | -2.71% | 649,243 | 311.51M |
| 87 | PGEN | Precigen, Inc. | 2.22B | -3.13% | 4,347,284 | 85.72M |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | 3.35% | 19,075,336 | 54.86M |
| 89 | AGIO | Agios Pharmaceuticals, Inc. | 2.21B | -0.51% | 920,052 | 98.34M |
| 90 | PHVS | Pharvaris N.V. | 2.21B | 2.38% | 621,711 | - |
| 91 | VCEL | Vericel Corporation | 2.18B | -1.02% | 494,731 | 306.30M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | 0.28% | 2,313,565 | 959.90M |
| 93 | BHVN | Biohaven Ltd. | 2.10B | -5.51% | 4,693,558 | - |
| 94 | IMNM | Immunome, Inc. | 2.04B | -1.48% | 1,378,903 | 4.02M |
| 95 | LKFT | Lakefront Biotherapeutics NV | 2.02B | 0.80% | 294,937 | 1.13B |
| 96 | VERA | Vera Therapeutics, Inc. | 2.02B | -3.65% | 1,982,083 | - |
| 97 | ZYME | Zymeworks Inc. | 2.00B | -0.77% | 1,123,557 | 37.13M |
| 98 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.28% | 177,568 | 6.13M |
| 99 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | 3.54% | 1,447,717 | 208.78M |
| 100 | SEPN | Septerna, Inc. | 1.89B | -1.15% | 200,318 | 98.88M |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.87B | -2.48% | 1,285,459 | 1.97B |
| 102 | XNCR | Xencor, Inc. | 1.87B | -2.55% | 1,458,065 | 104.97M |
| 103 | MLYS | Mineralys Therapeutics, Inc. | 1.82B | -4.29% | 1,089,746 | - |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.80B | -1.02% | 164,225 | - |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.80B | -2.55% | 1,377,028 | - |
| 106 | VIR | Vir Biotechnology, Inc. | 1.79B | 1.34% | 1,693,543 | 303.23M |
| 107 | ZBIO | Zenas BioPharma, Inc. | 1.75B | -4.82% | 377,550 | 1.00M |
| 108 | BRVE | Braveheart Bio, Inc. | 1.75B | -0.19% | 119,557 | - |
| 109 | MAZE | Maze Therapeutics, Inc. | 1.72B | -2.94% | 512,939 | 20.00M |
| 110 | URGN | UroGen Pharma Ltd. | 1.69B | -1.88% | 738,097 | 188.73M |
| 111 | KLRA | Kailera Therapeutics, Inc. | 1.67B | -3.17% | 1,560,584 | - |
| 112 | LYCA | Lycia Therapeutics, Inc. | 1.65B | 66.67% | 2,287,202 | 4.44M |
| 113 | MESO | Mesoblast Limited | 1.63B | -2.15% | 102,687 | 120.25M |
| 114 | STOK | Stoke Therapeutics, Inc. | 1.62B | -2.57% | 2,156,224 | 27.59M |
| 115 | COAG | Hemab Therapeutics Holdings, Inc. | 1.61B | -1.21% | 271,178 | - |
| 116 | NUVB | Nuvation Bio Inc. | 1.60B | -2.77% | 3,190,761 | 169.90M |
| 117 | NVAX | Novavax, Inc. | 1.60B | -2.90% | 4,418,716 | 413.80M |
| 118 | IMCR | Immunocore Holdings plc | 1.60B | -3.55% | 177,888 | 430.78M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.59B | -2.97% | 308,342 | 26.48M |
| 120 | ABSI | Absci Corporation | 1.58B | -2.03% | 1,890,073 | 1.56M |
| 121 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | 2.11% | 849,820 | - |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 0.45% | 3,566,570 | 59.51M |
| 123 | QURE | uniQure N.V. | 1.56B | -2.94% | 884,483 | 18.67M |
| 124 | RARE | Ultragenyx Pharmaceutical Inc. | 1.54B | -1.88% | 1,789,662 | 717.00M |
| 125 | GPCR | Structure Therapeutics Inc. | 1.51B | -3.37% | 798,110 | - |
| 126 | INVA | Innoviva, Inc. | 1.49B | -1.90% | 978,553 | 440.00M |
| 127 | NBTX | Nanobiotix S.A. | 1.47B | 0.58% | 69,409 | 13.15M |
| 128 | ANAB | AnaptysBio, Inc. | 1.46B | 1.31% | 468,215 | 106.09M |
| 129 | OCUL | Ocular Therapeutix, Inc. | 1.43B | -1.66% | 1,855,969 | 52.06M |
| 130 | KRSA | Korsana Biosciences, Inc. | 1.43B | -6.34% | 402,010 | - |
| 131 | AAPG | Ascentage Pharma Group International | 1.42B | 3.49% | 9,384 | 94.61M |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.41B | -2.01% | 520,381 | - |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -3.83% | 176,221 | 1.30M |
| 134 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -3.37% | 1,388,801 | - |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.30B | -2.86% | 359,785 | - |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -1.12% | 2,592,942 | 5.49M |
| 137 | NKTR | Nektar Therapeutics | 1.27B | -3.70% | 469,620 | 54.59M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.25B | -1.75% | 188,570 | - |
| 139 | RAPP | Rapport Therapeutics, Inc. | 1.24B | -2.26% | 1,185,460 | 20.00M |
| 140 | GHRS | GH Research PLC | 1.24B | -2.32% | 699,432 | - |
| 141 | VSTM | Verastem, Inc. | 1.22B | -0.20% | 3,762,127 | 87.53M |
| 142 | DRTS | Alpha Tau Medical Ltd. | 1.22B | 2.02% | 324,810 | - |
| 143 | OMER | Omeros Corporation | 1.20B | -1.72% | 699,390 | 38.42M |
| 144 | KARD | Kardigan, Inc. | 1.20B | 0.47% | 679,813 | - |
| 145 | SNDX | Syndax Pharmaceuticals, Inc. | 1.20B | -1.25% | 4,249,751 | 252.25M |
| 146 | SLN | Silence Therapeutics plc | 1.18B | 0.05% | 2,126,187 | 615.00K |
| 147 | AVLN | Avalyn Pharma Inc. | 1.15B | -4.44% | 320,313 | - |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.13B | -3.07% | 730,162 | - |
| 149 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -0.72% | 164,567 | - |
| 150 | VOR | Vor Biopharma Inc. | 1.08B | -3.59% | 720,971 | - |
| 151 | REPL | Replimune Group, Inc. | 1.08B | -4.42% | 1,905,060 | - |
| 152 | SVRA | Savara Inc. | 1.07B | -7.05% | 2,828,604 | - |
| 153 | AVBP | ArriVent BioPharma, Inc. | 1.04B | 9.38% | 3,278,558 | - |
| 154 | CTY | City Therapeutics, Inc. | 1.03B | - | 343,837 | 14.34M |
| 155 | MNKD | MannKind Corporation | 1.03B | -0.31% | 3,089,446 | 393.63M |
| 156 | JANX | Janux Therapeutics, Inc. | 1.02B | -2.34% | 378,884 | 24.00M |
| 157 | MLTX | MoonLake Immunotherapeutics | 1.01B | -3.97% | 1,935,821 | - |
| 158 | IMTX | Immatics N.V. | 999.20M | -3.05% | 695,979 | 47.65M |
| 159 | LTGO | Latigo Biotherapeutics, Inc. | 995.82M | -9.35% | 146,040 | - |
| 160 | SGP | SpyGlass Pharma, Inc. | 952.60M | 0.92% | 70,596 | - |
| 161 | ODTX | Odyssey Therapeutics, Inc. | 939.20M | 2.73% | 209,595 | 99.00K |
| 162 | JBIO | Jade Biosciences, Inc. | 927.89M | -2.15% | 634,377 | - |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 924.80M | -2.43% | 817,827 | 28.73M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 924.78M | -3.69% | 485,204 | - |
| 165 | RIGL | Rigel Pharmaceuticals, Inc. | 899.06M | -1.49% | 119,261 | 276.79M |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | 885.79M | -1.13% | 933,772 | - |
| 167 | MGTX | MeiraGTx Holdings plc | 884.56M | -5.73% | 596,805 | 397.50M |
| 168 | ALMS | Alumis Inc. | 877.57M | -0.59% | 1,230,177 | 7.40M |
| 169 | AKTS | Aktis Oncology, Inc. | 874.89M | -6.15% | 241,765 | 10.06M |
| 170 | OBX | Obsidian Therapeutics, Inc. | 863.58M | 0.29% | 279,757 | - |
| 171 | ANRO | Alto Neuroscience, Inc. | 862.15M | -1.04% | 379,247 | - |
| 172 | KURA | Kura Oncology, Inc. | 854.91M | -2.54% | 1,564,981 | 77.23M |
| 173 | ABUS | Arbutus Biopharma Corporation | 830.96M | -0.24% | 2,029,386 | 181.72M |
| 174 | IVA | Inventiva S.A. | 809.65M | 3.06% | 4,712,827 | 2.81M |
| 175 | PHAR | Pharming Group N.V. | 802.10M | 4.97% | 25,784 | 366.48M |
| 176 | APMD | Apnimed, Inc. | 790.57M | 2.48% | 277,300 | 115.12M |
| 177 | ARDX | Ardelyx, Inc. | 767.50M | -3.75% | 4,816,849 | 450.89M |
| 178 | HELP | Helus Pharma Inc. | 744.48M | -2.95% | 1,894,833 | - |
| 179 | GERN | Geron Corporation | 719.57M | -0.88% | 11,233,212 | 204.56M |
| 180 | ANNX | Annexon, Inc. | 710.92M | -1.57% | 2,575,608 | - |
| 181 | SANA | Sana Biotechnology, Inc. | 697.51M | -1.69% | 1,708,112 | - |
| 182 | ANL | Adlai Nortye Group Ltd. | 681.33M | - | 79,538 | 18.06M |
| 183 | SGMT | Sagimet Biosciences Inc. | 679.30M | -3.72% | 694,948 | - |
| 184 | OABI | OmniAb, Inc. | 677.52M | -2.51% | 1,283,245 | 38.46M |
| 185 | IAM | Iambic Therapeutics, Inc. | 675.94M | -2.79% | 610,324 | 18.25M |
| 186 | IMMX | Immix Biopharma, Inc. | 675.66M | -2.40% | 1,203,479 | - |
| 187 | DNA | Ginkgo Bioworks Holdings, Inc. | 672.73M | 2.88% | 1,156,111 | 132.42M |
| 188 | ACHV | Achieve Life Sciences, Inc. | 667.84M | -0.15% | 590,149 | - |
| 189 | SLBT | SL Science Holding Limited | 655.81M | -12.21% | 31,187 | 3.27M |
| 190 | AURA | Aura Biosciences, Inc. | 653.34M | -2.48% | 722,144 | - |
| 191 | NVCT | Nuvectis Pharma, Inc. | 653.26M | -4.02% | 107,947 | - |
| 192 | PRME | Prime Medicine, Inc. | 652.91M | -1.61% | 4,562,932 | 4.07M |
| 193 | DSGN | Design Therapeutics, Inc. | 640.84M | -2.38% | 210,366 | - |
| 194 | SLDB | Solid Biosciences Inc. | 634.77M | -4.36% | 769,968 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 631.84M | -4.70% | 2,684,899 | 41.47M |
| 196 | ATTO | Attovia Therapeutics, Inc. | 631.36M | -4.62% | 330,728 | 1.80M |
| 197 | WVE | Wave Life Sciences, Inc. | 626.61M | -5.07% | 2,655,917 | 65.37M |
| 198 | GYRE | Gyre Therapeutics, Inc. | 620.30M | -0.17% | 151,483 | 109.82M |
| 199 | CADL | Candel Therapeutics, Inc. | 614.44M | -4.18% | 1,184,816 | - |
| 200 | CRMD | CorMedix Inc. | 611.86M | -3.09% | 894,539 | 462.25M |
| 201 | FDMT | 4D Molecular Therapeutics, Inc. | 596.64M | -8.86% | 996,140 | 92.01M |
| 202 | CLYM | Climb Bio, Inc. | 585.28M | -3.32% | 495,694 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 582.55M | -5.03% | 978,005 | 136.07M |
| 204 | MDXG | MiMedx Group, Inc. | 569.92M | -0.51% | 1,262,560 | 355.17M |
| 205 | DBVT | DBV Technologies S.A. | 569.30M | 0.72% | 258,344 | 5.04M |
| 206 | PBYI | Puma Biotechnology, Inc. | 568.85M | -2.13% | 559,164 | 231.24M |
| 207 | OLMA | Olema Pharmaceuticals, Inc. | 560.86M | -8.69% | 1,984,563 | - |
| 208 | ACRS | Aclaris Therapeutics, Inc. | 552.00M | -2.09% | 2,290,474 | 8.22M |
| 209 | STTK | Shattuck Labs, Inc. | 550.99M | -1.96% | 700,503 | 1.00M |
| 210 | CBIO | Crescent Biopharma, Inc. | 548.71M | -2.44% | 397,809 | 11.88M |
| 211 | ETRA | Electra Therapeutics, Inc. | 546.70M | -5.84% | 186,456 | - |
| 212 | DRUG | Bright Minds Biosciences Inc. | 516.67M | -0.40% | 59,192 | - |
| 213 | ENTX | Entera Bio Ltd. | 507.85M | -3.31% | 256,927 | 42.00K |
| 214 | CTMX | CytomX Therapeutics, Inc. | 505.53M | -4.92% | 4,365,989 | 18.30M |
| 215 | VALN | Valneva SE | 493.97M | -1.87% | 6,408 | 163.30M |
| 216 | OCS | Oculis Holding AG | 487.68M | -2.35% | 294,728 | 1.45M |
| 217 | INDP | Indaptus Therapeutics, Inc. | 485.32M | 5.69% | 287,477 | - |
| 218 | ARVN | Arvinas, Inc. | 477.32M | -5.44% | 651,574 | 316.70M |
| 219 | MNPR | Monopar Therapeutics Inc. | 474.21M | -2.66% | 96,755 | - |
| 220 | NGNE | Neurogene Inc. | 471.27M | -3.01% | 124,512 | 925.00K |
| 221 | DMAC | DiaMedica Therapeutics Inc. | 470.23M | 1.04% | 110,030 | - |
| 222 | BLSM | BlossomHill Therapeutics, Inc. | 465.01M | -7.46% | 84,346 | - |
| 223 | PHAT | Phathom Pharmaceuticals, Inc. | 455.93M | -18.12% | 4,868,225 | 239.66M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.95M | -9.49% | 348,797 | - |
| 225 | SRZN | Surrozen, Inc. | 445.78M | -1.05% | 1,554,640 | 11.51M |
| 226 | AGMB | AgomAb Therapeutics NV | 445.69M | -2.27% | 52,224 | - |
| 227 | MPLT | MapLight Therapeutics, Inc. | 442.94M | -3.39% | 305,637 | - |
| 228 | FTH | Faeth Therapeutics, Inc. | 441.35M | -15.02% | 353,709 | - |
| 229 | RGNX | REGENXBIO Inc. | 440.97M | -6.83% | 1,452,353 | 174.48M |
| 230 | ALLO | Allogene Therapeutics, Inc. | 431.86M | - | 8,404,822 | 4.64M |
| 231 | PROK | ProKidney Corp. | 426.27M | -1.40% | 535,233 | 818.00K |
| 232 | OVID | Ovid Therapeutics Inc. | 421.84M | -8.86% | 2,017,390 | 1.58M |
| 233 | PRTA | Prothena Corporation plc | 420.96M | -0.61% | 386,146 | 54.53M |
| 234 | ALT | Altimmune, Inc. | 412.38M | -2.30% | 2,600,254 | 31.00K |
| 235 | NAUT | Nautilus Biotechnology, Inc. | 412.31M | 24.62% | 13,794,352 | 190.00K |
| 236 | AUTL | Autolus Therapeutics plc | 409.89M | -2.53% | 1,530,892 | 117.39M |
| 237 | RZLT | Rezolute, Inc. | 404.38M | -0.13% | 1,198,116 | - |
| 238 | ASMB | Assembly Biosciences, Inc. | 403.95M | -2.17% | 206,013 | 74.85M |
| 239 | SPRY | ARS Pharmaceuticals, Inc. | 400.77M | -6.71% | 1,522,196 | 116.93M |
| 240 | EIKN | Eikon Therapeutics, Inc. | 393.24M | -11.89% | 318,443 | - |
| 241 | TECX | Tectonic Therapeutic, Inc. | 392.36M | -4.84% | 144,970 | - |
| 242 | CCCC | C4 Therapeutics, Inc. | 376.46M | -3.77% | 4,741,850 | 35.04M |
| 243 | PRLD | Prelude Therapeutics Incorporated | 373.87M | 0.83% | 288,578 | 22.42M |
| 244 | TRXB | TRex Bio, Inc. | 371.79M | -10.90% | 81,180 | - |
| 245 | AVTX | Avalo Therapeutics, Inc. | 371.66M | -6.98% | 4,551,356 | 59.00K |
| 246 | EDIT | Editas Medicine, Inc. | 368.59M | -3.61% | 1,313,713 | 47.01M |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 353.48M | -2.33% | 70,821 | 59.22M |
| 248 | YDES | YD Bio Limited | 350.62M | 16.75% | 105,145 | 1.24M |
| 249 | RLMD | Relmada Therapeutics, Inc. | 348.81M | -0.61% | 1,100,741 | - |
| 250 | CAPR | Capricor Therapeutics, Inc. | 344.76M | -3.26% | 1,464,348 | 11.13M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 339.02M | 0.17% | 228,231 | 65.26M |
| 252 | OBIO | Orchestra BioMed Holdings, Inc. | 335.99M | 2.19% | 262,035 | 31.98M |
| 253 | KYTX | Kyverna Therapeutics, Inc. | 333.34M | -5.93% | 827,751 | - |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 324.03M | -0.25% | 245,442 | - |
| 255 | ZURA | Zura Bio Limited | 321.99M | -4.82% | 5,824,413 | - |
| 256 | GALT | Galectin Therapeutics Inc. | 321.71M | -5.62% | 195,220 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 321.24M | 1.25% | 536,761 | 15.85M |
| 258 | VTVT | vTv Therapeutics Inc. | 317.45M | -5.93% | 21,622 | 36.84M |
| 259 | CTNM | Contineum Therapeutics, Inc. | 312.63M | -1.07% | 428,770 | - |
| 260 | TTRX | Turn Therapeutics Inc. | 306.22M | 0.98% | 87,050 | - |
| 261 | BNTC | Benitec Biopharma Inc. | 301.74M | -1.93% | 158,391 | - |
| 262 | ARTV | Artiva Biotherapeutics, Inc. | 300.67M | -0.81% | 315,490 | 251.00K |
| 263 | SCTX | Scribe Therapeutics Inc. | 291.64M | -14.23% | 861,603 | 33.30M |
| 264 | IKT | Inhibikase Therapeutics, Inc. | 289.50M | -2.45% | 408,795 | 1.00 |
| 265 | IRD | Opus Genetics, Inc. | 288.69M | -9.16% | 1,118,007 | 9.86M |
| 266 | AGEN | Agenus Inc. | 284.98M | -2.76% | 510,514 | 132.69M |
| 267 | FULC | Fulcrum Therapeutics, Inc. | 280.77M | - | 1,067,350 | 80.00M |
| 268 | ARCT | Arcturus Therapeutics Holdings Inc. | 279.68M | -8.29% | 474,965 | 29.37M |
| 269 | ALEC | Alector, Inc. | 271.31M | - | 2,035,035 | 13.86M |
| 270 | VCRE | Vicore Pharma Holding AB (publ) | 269.98M | -9.11% | 28,417 | 412.09K |
| 271 | IPSC | Century Therapeutics, Inc. | 264.37M | -7.59% | 892,067 | 109.16M |
| 272 | VOGX | Vogenx, Inc. | 259.22M | -8.54% | 64,475 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 258.40M | -6.58% | 1,015,771 | 114.70K |
| 274 | QTTB | Q32 Bio Inc. | 257.51M | -1.70% | 404,053 | 53.74M |
| 275 | LCTX | Lineage Cell Therapeutics, Inc. | 252.91M | 1.52% | 1,150,710 | 13.08M |
| 276 | FATE | Fate Therapeutics, Inc. | 252.82M | 0.96% | 1,111,188 | 6.49M |
| 277 | ABEO | Abeona Therapeutics Inc. | 251.61M | -1.57% | 797,294 | 25.52M |
| 278 | RCKT | Rocket Pharmaceuticals, Inc. | 251.38M | -0.87% | 1,601,101 | - |
| 279 | OCGN | Ocugen, Inc. | 250.84M | -6.37% | 8,585,243 | 4.58M |
| 280 | CABA | Cabaletta Bio, Inc. | 249.23M | -3.29% | 3,991,692 | - |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 248.63M | -1.79% | 4,713 | 65.05M |
| 282 | BCYC | Bicycle Therapeutics plc | 248.47M | -2.47% | 346,808 | 61.21M |
| 283 | LRMR | Larimar Therapeutics, Inc. | 245.30M | 3.52% | 1,143,989 | - |
| 284 | VNDA | Vanda Pharmaceuticals Inc. | 242.46M | -0.99% | 830,813 | 215.72M |
| 285 | IMRX | Immuneering Corporation | 241.32M | -2.10% | 726,539 | - |
| 286 | ACIU | AC Immune SA | 240.61M | -3.20% | 139,550 | 21.67M |
| 287 | GLSI | Greenwich LifeSciences, Inc. | 235.29M | 3.55% | 86,520 | - |
| 288 | PALI | Palisade Bio, Inc. | 231.78M | -1.48% | 1,333,929 | 500.00K |
| 289 | LYEL | Lyell Immunopharma, Inc. | 230.10M | 0.11% | 101,637 | 27.00K |
| 290 | IFRX | InflaRx N.V. | 229.89M | 1.96% | 889,583 | -11.54K |
| 291 | LXEO | Lexeo Therapeutics, Inc. | 229.72M | -3.11% | 619,383 | - |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 227.38M | 3.06% | 57,770 | 1.80M |
| 293 | KROS | Keros Therapeutics, Inc. | 223.65M | -0.62% | 120,902 | 15.01M |
| 294 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 213.26M | -6.67% | 737,353 | - |
| 295 | ZNTL | Zentalis Pharmaceuticals, Inc. | 209.22M | -8.30% | 947,073 | 26.87M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 207.09M | -2.65% | 284,947 | 4.22M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 205.46M | -0.78% | 383,908 | 80.62M |
| 298 | PYXS | Pyxis Oncology, Inc. | 200.69M | -1.75% | 626,779 | 11.04M |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 187.09M | - | 420,025 | - |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 186.98M | -3.59% | 85,902 | 1.48M |
| 301 | EVMN | Evommune, Inc. | 185.09M | -2.11% | 280,829 | 10.00M |
| 302 | CGEN | Compugen Ltd. | 183.76M | -1.02% | 148,021 | 74.00M |
| 303 | DTIL | Precision BioSciences, Inc. | 183.27M | -2.06% | 275,533 | 45.06M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 183.00M | -1.23% | 222,612 | 7.15M |
| 305 | PRQR | ProQR Therapeutics N.V. | 182.05M | -3.01% | 1,785,936 | 21.05M |
| 306 | ACOG | Alpha Cognition Inc. | 181.63M | 0.36% | 134,714 | 15.26M |
| 307 | IVVD | Invivyd, Inc. | 180.81M | 0.54% | 2,762,894 | 58.37M |
| 308 | YARW | Yarrow Bioscience, Inc. | 179.30M | -1.68% | 149,995 | - |
| 309 | KRRO | Korro Bio, Inc. | 176.41M | -0.58% | 237,437 | 2.38M |
| 310 | PEPG | PepGen Inc. | 174.53M | -6.67% | 1,161,743 | - |
| 311 | ORMP | Oramed Pharmaceuticals Inc. | 171.80M | 0.24% | 115,663 | 2.00M |
| 312 | SION | Sionna Therapeutics, Inc. | 162.76M | -5.26% | 918,199 | - |
| 313 | ADAG | Adagene Inc. | 161.82M | -1.23% | 167,166 | 9.29M |
| 314 | ALXO | ALX Oncology Holdings Inc. | 161.78M | -1.68% | 556,402 | - |
| 315 | TRDA | Entrada Therapeutics, Inc. | 159.01M | -6.77% | 191,472 | 4.69M |
| 316 | NBP | NovaBridge Biosciences | 158.92M | 3.01% | 558,749 | - |
| 317 | CHRS | Coherus Oncology, Inc. | 156.05M | -3.81% | 641,451 | 50.94M |
| 318 | MDWD | MediWound Ltd. | 154.92M | -1.48% | 79,258 | 11.86M |
| 319 | STRO | Sutro Biopharma, Inc. | 154.70M | -9.33% | 430,837 | 45.70M |
| 320 | NGEN | NervGen Pharma Corp. | 153.76M | 0.70% | 944,031 | - |
| 321 | UPB | Upstream Bio, Inc. | 150.07M | -8.36% | 1,051,217 | 3.16M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 148.21M | - | 329,567 | 1.50M |
| 323 | MOLN | Molecular Partners AG | 145.80M | 1.69% | 4,309 | 856.30K |
| 324 | MGNX | MacroGenics, Inc. | 143.33M | -38.02% | 4,009,665 | 175.14M |
| 325 | ABOS | Acumen Pharmaceuticals, Inc. | 143.19M | -3.88% | 541,794 | - |
| 326 | VRXA | Veraxa Biotech AG | 141.41M | -2.91% | 137,877 | 29.54K |
| 327 | RNA | Atrium Therapeutics, Inc. | 140.27M | 0.49% | 192,660 | 35.84M |
| 328 | CDXS | Codexis, Inc. | 140.17M | -2.29% | 546,625 | 77.68M |
| 329 | HURA | TuHURA Biosciences, Inc. | 138.92M | 8.46% | 1,013,965 | - |
| 330 | MSLE | Satellos Bioscience Inc. | 138.49M | -3.17% | 33,722 | - |
| 331 | TARA | Protara Therapeutics, Inc. | 137.69M | -4.51% | 867,582 | - |
| 332 | CMPX | Compass Therapeutics, Inc. | 137.05M | -5.05% | 2,128,369 | 850.00K |
| 333 | IPHA | Innate Pharma S.A. | 135.78M | - | 11,924 | 11.21M |
| 334 | CUE | Cue Biopharma, Inc. | 135.55M | -1.22% | 79,367 | 37.66M |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 135.34M | 5.51% | 115,591 | 5.54M |
| 336 | ANTX | AN2 Therapeutics, Inc. | 133.96M | -2.47% | 124,440 | - |
| 337 | MENS | Jyong Biotech Ltd. | 131.39M | 1.72% | 60,016 | - |
| 338 | SPRB | Spruce Biosciences, Inc. | 129.76M | -1.85% | 73,817 | 697.00K |
| 339 | NKTX | Nkarta, Inc. | 128.21M | 2.87% | 959,153 | - |
| 340 | RTSN | Retension Pharmaceuticals, Inc. | 127.06M | -1.61% | 77,907 | - |
| 341 | OTLK | Outlook Therapeutics, Inc. | 126.42M | -7.84% | 3,082,823 | -1.16M |
| 342 | AVXL | Anavex Life Sciences Corp. | 123.29M | -2.21% | 627,215 | - |
| 343 | TLSA | Tiziana Life Sciences Ltd | 121.64M | -4.99% | 252,201 | - |
| 344 | HUMA | Humacyte, Inc. | 120.95M | 5.40% | 2,607,709 | 2.12M |
| 345 | FHTX | Foghorn Therapeutics Inc. | 118.77M | -0.50% | 486,823 | 36.74M |
| 346 | NERV | Minerva Neurosciences, Inc. | 109.82M | -4.17% | 137,589 | - |
| 347 | SEER | Seer, Inc. | 109.08M | - | 147,081 | 14.22M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 108.36M | -1.27% | 1,212,427 | - |
| 349 | BDTX | Black Diamond Therapeutics, Inc. | 108.01M | -9.62% | 927,810 | 70.00M |
| 350 | CBUS | Cibus, Inc. | 107.76M | 0.71% | 45,977 | 4.35M |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 107.72M | 3.75% | 840,297 | 3.39M |
| 352 | VYGR | Voyager Therapeutics, Inc. | 107.22M | -6.45% | 1,052,312 | 34.46M |
| 353 | KZIA | Kazia Therapeutics Limited | 107.03M | -3.22% | 52,676 | 1.27M |
| 354 | PYPD | PolyPid Ltd. | 106.64M | 2.34% | 104,234 | - |
| 355 | ENGN | enGene Therapeutics Inc. | 104.55M | -1.27% | 730,199 | - |
| 356 | ANIX | Anixa Biosciences, Inc. | 103.94M | 7.55% | 326,688 | - |
| 357 | TVGN | Tevogen Inc. | 102.76M | -4.11% | 39,414 | - |
| 358 | OKUR | OnKure Therapeutics, Inc. | 102.05M | -2.33% | 240,864 | - |
| 359 | IMUX | Immunic, Inc. | 101.11M | 2.63% | 367,164 | - |
| 360 | VANI | Vivani Medical, Inc. | 100.13M | 1.83% | 85,846 | - |
| 361 | LENZ | LENZ Therapeutics, Inc. | 99.29M | -2.77% | 696,456 | 21.48M |
| 362 | TENX | Tenax Therapeutics, Inc. | 98.52M | -2.27% | 854,386 | - |
| 363 | PMVP | PMV Pharmaceuticals, Inc. | 95.90M | -2.68% | 171,002 | - |
| 364 | ICCC | ImmuCell Corporation | 93.09M | -1.82% | 11,335 | 30.68M |
| 365 | NRXS | NeurAxis, Inc. | 92.93M | -2.63% | 75,208 | 5.32M |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 92.76M | 6.94% | 3,930,159 | 65.34K |
| 367 | COYA | Coya Therapeutics, Inc. | 92.42M | -4.83% | 188,645 | 8.02M |
| 368 | PLYX | Polaryx Therapeutics, Inc. | 92.22M | -4.64% | 43,032 | - |
| 369 | MIST | Milestone Pharmaceuticals Inc. | 91.34M | -7.76% | 1,576,365 | 2.34M |
| 370 | GNLX | Genelux Corporation | 89.62M | 1.01% | 648,745 | 8.00K |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 88.67M | 0.78% | 754,751 | 29.10M |
| 372 | RLYB | Rallybio Corporation | 88.37M | 1.46% | 6,186 | 646.00K |
| 373 | CNXU | Conexeu Sciences Inc. | 87.44M | -6.06% | 167,706 | - |
| 374 | TNYA | Tenaya Therapeutics, Inc. | 87.23M | 0.26% | 1,698,851 | 1.34M |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 86.22M | -8.91% | 24,320 | 6.19M |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 84.46M | 3.11% | 290,767 | 4.88M |
| 377 | NTHI | NeOnc Technologies Holdings, Inc. | 81.28M | 10.85% | 380,853 | 39.99K |
| 378 | PDSB | PDS Biotechnology Corporation | 80.45M | -4.31% | 2,704,087 | - |
| 379 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 78.33M | -1.94% | 372,925 | - |
| 380 | EQ | Equillium, Inc. | 77.99M | -3.15% | 315,664 | 4.39M |
| 381 | CLLS | Cellectis S.A. | 76.40M | 0.51% | 13,628 | 63.82M |
| 382 | PMN | ProMIS Neurosciences, Inc. | 74.79M | -7.13% | 10,442 | - |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 74.14M | -1.70% | 108,179 | - |
| 384 | OKYO | OKYO Pharma Limited | 73.47M | -4.76% | 13,848 | - |
| 385 | CING | Cingulate Inc. | 72.42M | 6.87% | 81,092 | - |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 71.79M | -3.46% | 50,162 | - |
| 387 | NMRA | Neumora Therapeutics, Inc. | 71.29M | -6.48% | 835,857 | - |
| 388 | CRDF | Cardiff Oncology, Inc. | 70.58M | -2.23% | 174,708 | 508.00K |
| 389 | NTRB | Nutriband Inc. | 70.02M | -0.86% | 6,783 | 1.62M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 69.95M | 1.77% | 141,088 | - |
| 391 | MNOV | MediciNova, Inc. | 68.42M | -1.42% | 25,509 | 920.48K |
| 392 | CGTX | Cognition Therapeutics, Inc. | 68.35M | 2.60% | 571,537 | - |
| 393 | CSBR | Champions Oncology, Inc. | 65.70M | -0.84% | 3,676 | 60.66M |
| 394 | PTHS | Pelthos Therapeutics Inc. | 65.08M | -13.22% | 57,783 | 43.30M |
| 395 | SPRO | Spero Therapeutics, Inc. | 64.64M | -1.77% | 316,553 | 47.00M |
| 396 | FBIO | Fortress Biotech, Inc. | 64.37M | -3.02% | 223,618 | 68.47M |
| 397 | ONCY | Oncolytics Biotech Inc. | 64.05M | 0.42% | 376,007 | - |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 60.64M | -7.83% | 21,006 | 30.32M |
| 399 | XBIT | XBiotech Inc. | 58.84M | -2.03% | 121,737 | - |
| 400 | GOSS | Gossamer Bio, Inc. | 58.75M | 1.53% | 144,834 | 53.29M |
| 401 | RNXT | RenovoRx, Inc. | 58.22M | 1.57% | 284,140 | 1.98M |
| 402 | OSTX | OS Therapies Incorporated | 57.76M | - | 142,128 | - |
| 403 | HRTX | Heron Therapeutics, Inc. | 57.49M | 2.23% | 1,308,953 | 151.18M |
| 404 | CRBU | Caribou Biosciences, Inc. | 57.12M | -4.86% | 2,155,514 | 10.04M |
| 405 | CLNN | Clene Inc. | 55.15M | - | 21,397 | 197.00K |
| 406 | GANX | Gain Therapeutics, Inc. | 54.99M | -2.33% | 645,034 | - |
| 407 | INKT | MiNK Therapeutics, Inc. | 54.65M | 6.46% | 29,538 | - |
| 408 | HYFT | MindWalk Holdings Corp. | 54.65M | -3.33% | 285,507 | 11.57M |
| 409 | ALPS | Alps Group Inc | 54.58M | 0.03% | 20,797 | 3.74M |
| 410 | BOLD | Boundless Bio, Inc. | 53.68M | -3.28% | 34,870 | - |
| 411 | PLRX | Pliant Therapeutics, Inc. | 53.48M | -0.20% | 446,817 | - |
| 412 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.67M | -2.44% | 27,606 | - |
| 413 | RNTX | Rein Therapeutics Inc. | 50.22M | -3.37% | 331,333 | - |
| 414 | ELTX | Elicio Therapeutics, Inc. | 49.94M | -2.06% | 464,095 | - |
| 415 | XLO | Xilio Therapeutics, Inc. | 49.81M | -5.73% | 16,254 | 64.09M |
| 416 | CNTB | Connect Biopharma Holdings Limited | 48.27M | 0.58% | 344,584 | 2.95M |
| 417 | APLM | Apollomics, Inc. | 47.96M | -0.73% | 7,160 | 8.84M |
| 418 | IMA | ImageneBio, Inc. | 47.90M | 4.33% | 7,869 | 800.00K |
| 419 | ATNM | Actinium Pharmaceuticals, Inc. | 47.79M | -5.00% | 242,011 | 35.09M |
| 420 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | -2.96% | 211,036 | 21.00M |
| 421 | IBIO | iBio, Inc. | 46.16M | -8.44% | 655,171 | 100.00K |
| 422 | LONA | LeonaBio, Inc. | 45.60M | -2.62% | 33,791 | - |
| 423 | MREO | Mereo BioPharma Group plc | 44.98M | -1.98% | 524,230 | 500.00K |
| 424 | KLRS | Kalaris Therapeutics, Inc. | 44.52M | -6.03% | 25,407 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 43.51M | -4.11% | 202,583 | 1.40M |
| 426 | BMEA | Biomea Fusion, Inc. | 43.50M | 2.58% | 958,013 | - |
| 427 | ACET | Adicet Bio, Inc. | 42.95M | -6.78% | 162,967 | - |
| 428 | ESLA | Estrella Immunopharma, Inc. | 42.85M | 35.53% | 3,718,721 | - |
| 429 | ATHE | Alterity Therapeutics Limited | 42.70M | -2.79% | 26,791 | 2.50M |
| 430 | ANVS | Annovis Bio, Inc. | 42.58M | 0.77% | 317,231 | - |
| 431 | SER | Serina Therapeutics, Inc. | 41.91M | -6.25% | 8,002 | 130.00K |
| 432 | GRCE | Grace Therapeutics, Inc. | 40.60M | 0.78% | 47,222 | - |
| 433 | INMB | INmune Bio Inc. | 40.52M | -5.19% | 190,564 | 50.00K |
| 434 | GRDX | GridAI Technologies Corp. | 39.69M | 2.09% | 254,602 | - |
| 435 | TIL | Instil Bio, Inc. | 39.61M | 2.46% | 121,348 | - |
| 436 | ALDX | Aldeyra Therapeutics, Inc. | 39.19M | 0.68% | 821,843 | - |
| 437 | VERU | Veru Inc. | 38.19M | -2.18% | 122,593 | 16.89M |
| 438 | DWTX | Dogwood Therapeutics, Inc. | 38.07M | - | 24,586 | - |
| 439 | EDSA | Edesa Biotech, Inc. | 37.43M | 0.36% | 18,558 | - |
| 440 | EXOZ | eXoZymes, Inc. | 37.13M | 2.56% | 14,308 | -700.00 |
| 441 | NNVC | NanoViricides, Inc. | 35.74M | 0.72% | 159,574 | - |
| 442 | LITS | Lite Strategy, Inc. | 35.27M | -2.52% | 141,127 | - |
| 443 | CRVO | CervoMed Inc. | 34.93M | 3.12% | 111,784 | 331.30K |
| 444 | EYPT | EyePoint, Inc. | 34.87M | -5.51% | 13,330,728 | 2.79M |
| 445 | IRLA | IRulya Therapeutics Inc. | 33.64M | 0.76% | 89,785 | - |
| 446 | CELU | Celularity Inc. | 31.73M | -6.89% | 145,347 | 18.67M |
| 447 | EVAX | Evaxion A/S | 31.36M | 1.35% | 161,905 | 7.49M |
| 448 | IBO | Impact BioMedical Inc. | 30.76M | -5.26% | 11,828 | 35.00K |
| 449 | FLNA | Filana Therapeutics, Inc. | 30.70M | -2.84% | 313,552 | - |
| 450 | MGX | Metagenomi Therapeutics, Inc. | 30.43M | -1.30% | 76,731 | 13.56M |
| 451 | AARD | Aardvark Therapeutics, Inc. | 30.42M | -64.81% | 16,346,519 | - |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 29.97M | 3.21% | 32,683 | - |
| 453 | ALGS | Aligos Therapeutics, Inc. | 29.85M | -0.83% | 4,849 | 31.52M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 29.79M | 0.73% | 65,859 | - |
| 455 | BSEM | BioStem Technologies, Inc. | 29.18M | -5.42% | 134,010 | 34.59M |
| 456 | CVM | CEL-SCI Corporation | 28.85M | 1.86% | 41,897 | - |
| 457 | ABVC | ABVC BioPharma, Inc. | 27.00M | -0.67% | 22,011 | 797.92K |
| 458 | ATOS | Atossa Therapeutics, Inc. | 25.95M | -4.41% | 77,025 | - |
| 459 | IGC | IGC Pharma, Inc. | 25.43M | -0.69% | 124,238 | 1.11M |
| 460 | IMMP | Immutep Limited | 23.84M | 0.95% | 7,942 | 13.79M |
| 461 | NXTC | NextCure, Inc. | 22.80M | 5.51% | 48,546 | - |
| 462 | CNTX | Context Therapeutics Inc. | 21.99M | 1.57% | 1,485,419 | - |
| 463 | PLRZ | Polyrizon Ltd. | 21.19M | 0.06% | 16,296 | - |
| 464 | MCRB | Seres Therapeutics, Inc. | 20.99M | -1.88% | 69,713 | 1.88M |
| 465 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.31M | 0.25% | 2,541 | - |
| 466 | QNTM | Quantum BioPharma Ltd. | 18.97M | -1.32% | 42,708 | - |
| 467 | AKTX | Akari Therapeutics, Plc | 18.80M | 1.54% | 14,400 | - |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 18.61M | -1.15% | 73,020 | 1.17M |
| 469 | KYNB | Kyntra Bio, Inc. | 18.55M | -12.26% | 44,024 | 4.62M |
| 470 | COCP | Cocrystal Pharma, Inc. | 18.30M | 4.17% | 43,538 | 330.00K |
| 471 | BYSI | BeyondSpring Inc. | 17.73M | -3.15% | 19,765 | 1.88M |
| 472 | JSPR | Jasper Therapeutics, Inc. | 16.97M | 2.91% | 323,720 | - |
| 473 | ATYR | aTyr Pharma, Inc. | 16.19M | -2.88% | 1,300,887 | 190.00K |
| 474 | MRKR | Marker Therapeutics, Inc. | 16.01M | -10.27% | 116,806 | 3.55M |
| 475 | PBM | Psyence Biomedical Ltd. | 15.89M | 1.09% | 13,184 | - |
| 476 | NCEL | NewcelX Ltd. | 15.36M | 3.91% | 10,357 | - |
| 477 | RADX | Radiopharm Theranostics Limited | 15.25M | 6.32% | 32,465 | 8.90M |
| 478 | KPRX | Kiora Pharmaceuticals, Inc. | 14.57M | -1.29% | 24,424 | 20.00K |
| 479 | DYAI | Dyadic International, Inc. | 14.54M | -0.75% | 40,826 | 3.80M |
| 480 | GUTS | Fractyl Health, Inc. | 14.33M | -4.42% | 437,902 | 3.00K |
| 481 | BCDA | BioCardia, Inc. | 13.94M | -0.83% | 40,316 | 3.00K |
| 482 | TCRX | TScan Therapeutics, Inc. | 13.77M | -6.01% | 262,783 | 7.11M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 13.77M | 2.22% | 71,070 | 345.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 13.53M | -9.05% | 1,533,406 | - |
| 485 | DARE | Daré Bioscience, Inc. | 12.70M | -0.89% | 56,544 | 1.37M |
| 486 | ICU | SeaStar Medical Holding Corporation | 12.68M | -15.44% | 343,423 | 1.71M |
| 487 | HIND | Vyome Holdings, Inc. | 12.56M | -0.56% | 2,253 | 129.73K |
| 488 | TVRD | Tvardi Therapeutics, Inc. | 12.54M | -3.31% | 108,871 | - |
| 489 | CNSY | Cerenome, Inc. | 12.45M | -6.29% | 62,575 | 4.20M |
| 490 | PLUR | Pluri Inc. | 12.22M | -1.98% | 70,237 | 1.02M |
| 491 | BOLT | Bolt Biotherapeutics, Inc. | 12.08M | 49.64% | 12,882,703 | 4.70M |
| 492 | AEON | AEON Biopharma, Inc. | 11.97M | 2.65% | 199,468 | - |
| 493 | LPCN | Lipocine Inc. | 11.87M | -1.37% | 218,656 | 1.57M |
| 494 | KPTI | Karyopharm Therapeutics Inc. | 11.74M | -5.24% | 1,963,966 | 146.62M |
| 495 | CLRB | Cellectar Biosciences, Inc. | 11.53M | 4.27% | 58,228 | - |
| 496 | ACTU | Actuate Therapeutics, Inc. | 11.41M | -7.94% | 256,149 | - |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 11.07M | 8.79% | 435,499 | 7.11M |
| 498 | GDTC | CytoMed Therapeutics Limited | 10.97M | - | 4,848 | 609.73K |
| 499 | PASG | Passage Bio, Inc. | 10.84M | -3.99% | 21,535 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 10.61M | 1.88% | 6,412 | - |